Kiniksa Pharmaceuticals International, plc

Healthcare · Drug Manufacturers - Specialty & Generic · United Kingdom

Last price 97.56 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.67B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericard...